Skip to content

Efferon® NEO

by Efferon OÜ Estonia EUDAMED

Ref REF 24LEU002Model Efferon® LPS, Efferon® NEO

EMDN C03010104

Regulatory status

as of 25 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDR Number2024-MDR/QS-024/A Date7 Apr 2026IssuedStatusActive expires 22 Apr 2029

Coverage

1 jurisdiction

SwedenFinlandFinlandSwedenFinlandFinlandSwedenSwedenLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyGermanyPolandPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaPolandFranceFranceAustriaHungaryRomaniaFranceFranceSloveniaBulgariaPortugalSpainSpainItalySpainSpainCroatiaGreeceMaltaCyprus
  • Active
  • Not covered

European Union — CE/MDR Active

Certificates

1 certificate · EUDAMED

EUDAMED certificates (1)
  • 2024-MDR/QS-024/A Issued

    Quality management system EU MDR

    Notified body
    3EC International a.s. 2265
    Issued
    7 Apr 2026
    Expires
    22 Apr 2029

Specification

EUDAMED · synced 22 Oct 2026

Device Name
Extracorporeal blood adsorber
Model / Reference
Efferon® LPS, Efferon® NEO, REF 24LEU002
Primary DI / UDI-DI
04745011021656
Basic UDI-DI
47450110216EfferonLPS7K
Direct Marketing DI
04745011021656
EMDN Code
C03010104 Extracorporeal circulation filters
Device Class
Class IIb
Market of Registration
Estonia

Manufacturer details

EUDAMED SRN
EE-MF-000024299

From the manufacturer

Manufacturer's product page: Efferon NEOPediatric

Other devices from Efferon OÜ

  • Efferon® LPS

    Class IIb

Properties & raw data

Show properties, registry sources and raw records
  • Sterile
Other properties (12)
  • Implantable: No
  • Reusable: No
  • Contains Latex: No
  • Reprocessed: No
  • CMR Substance: No
  • Human-derived: No
  • Human Tissues: No
  • Animal Tissues: No
  • Endocrine Disruptor: No
  • Administering Medicine: No
  • Measuring Function: No
  • Incorporates Medicinal Product: No

Sources (1)

  • EUDAMED 97a4e4b5-3b33-4ef6-b737-11c3b88bfc96 61 fields · synced 22 Oct 2026